Evidence map›Paper›PMID 27520277›Full record

ReviewMolecular neurobiology2017

The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review.

Anahita Kiasatdolatabadi, Nasrin Lotfibakhshaiesh, Meysam Yazdankhah, Somayeh Ebrahimi-Barough, Mina Jafarabadi, Arman Ai, Esmaeil Sadroddiny, Jafar Ai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. The complex aetiology of cerebral palsy.Nature reviews. Neurology · 2018
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Anahita KiasatdolatabadiDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran.
Nasrin LotfibakhshaieshDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran.
Meysam YazdankhahDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran.
Somayeh Ebrahimi-BaroughDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran.
Mina JafarabadiReproductive health research centre, Tehran University of medical sciences, Tehran, Iran.
Arman AiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Esmaeil SadroddinyDepartment of Medical Biotechnology, School of Advanced Technologies in Medicine, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Jafar AiDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of medical sciences, 88, 10th floor, Italia Str., Keshavarz Blv, Tehran, Iran. jafar_ai@tums.ac.ir.
University of Tehran · IRTehran University of Medical Sciences · IRJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral palsy (CP) is a neuromuscular disease due to injury in the infant's brain. The CP disorder causes many neurologic dysfunctions in the patient. Various treatment methods have been used for the management of CP disorder. However, there has been no absolute cure for this condition. Furthermore, some of the procedures which are currently used for relief of symptoms in CP cause discomfort or side effects in the patient. Recently, stem cell therapy has attracted a huge interest as a new therapeutic method for treatment of CP. Several investigations in animal and human with CP have demonstrated positive potential of stem cell transplantation for the treatment of CP disorder. The ultimate goal of this therapeutic method is to harness the regenerative capacity of the stem cells causing a formation of new tissues to replace the damaged tissue. During the recent years, there have been many investigations on stem cell therapy. However, there are still many unclear issues regarding this method and high effort is needed to create a technology as a perfect treatment. This review will discuss the scientific background of stem cell therapy for cerebral palsy including evidences from current clinical trials.

Indexed as

Stem Cell TransplantationAnimalsBrainBrain InjuriesCell DifferentiationCerebral PalsyHumansNeural Stem CellsCerebral palsyClinical trialsStem cellTreatment

Identifiers

PMID27520277
OpenAlexW2510857970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.